Health

AstraZeneca Trial Failure

Updated 2026-09-14 13:25 UTC 1 source Negative

AstraZeneca's breast cancer pill failed in a pivotal trial as a first-line therapy for advanced tumors.

Coverage timeline — 1 article
STAT News
AstraZeneca disclosed that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors
2026-09-14 13:07 UTC
Share: Twitter / X LinkedIn